Intracranial Aneurysm
Conditions
Interventions
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1)Age between 18 and 80 years old. (2)Diagnosed with symptomatic intracranial atherosclerotic stenosis or intracranial aneurysm and scheduled for stenting therapy. (3)Modified Rankin Scale (mRS) score <= 2 at admission. (4)Capable of understanding and signing the informed consent form, and willing to participate in the study. (5)Able to cooperate with follow-up visits and evaluations.
Exclusion criteria
Exclusion criteria: (1)Patients with a severe bleeding tendency or active bleeding. (2)Pregnant or lactating women. (3)Patients allergic to aspirin, clopidogrel, indobufen, or contrast agents. (4)Patients with congenital aneurysmal cerebral vascular malformations (AVM) or other cerebrovascular abnormalities unrelated to the treatment of arterial stenosis. (5)Patients with severe hepatic or renal insufficiency. (6)Patients with severe cognitive impairment or psychiatric disorders that may affect treatment compliance or follow-up evaluations. (7)Patients in the acute phase of stroke (onset = 1 week). (8)Patients with severe cardiopulmonary diseases unsuitable for endovascular treatment. (9)Patients who have previously experienced adverse reactions or complications related to participation in endovascular treatment studies. (10)Patients with severe autoimmune diseases. (11)Patients with active infectious diseases, such as sepsis or tuberculosis. (12)Patients with autonomic nervous system disorders that may affect treatment efficacy or follow-up evaluations. (13)Patients who have previously participated in other clinical trials or experimental drug studies, unless the treatment regimen does not conflict with this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| New ischemic stroke or TIA events; | — |
Secondary
| Measure | Time frame |
|---|---|
| New cerebral infarction lesions on imaging;Target vessel restenosis ;Cerebral hemorrhage and/or all-cause mortality ;Deep vein thrombosis (DVT) in the lower extremities ; | — |
Countries
China
Contacts
Public ContactJiachun Liu
Beijing Hospital
Outcome results
None listed